Fovista

Ophthotech completes clean sweep of phase 3 trial flops
Fierce Biotech
Mon, 08/14/17 - 10:06 am
Ophthotech
clinical trials
Fovista
wet age-related macular degeneration
Novartis hits pause on Fovista agreement
BioPharma Dive
Mon, 07/10/17 - 11:21 pm
Novartis
Fovista
Ophthotech
wet age-related macular degeneration
Ophthotech cuts to hit around 80% of staffers after phase 3 failures
Fierce Biotech
Wed, 01/18/17 - 10:03 am
layoffs
Ophthotech
Fovista
Reeling Ophthotech eviscerates staff, laying off up to 135; Booming Regeneron adds more space
Endpoints
Fri, 12/16/16 - 09:50 am
Ophthotech
layoffs
Fovista
Regeneron
What Fovista's Fail Means For OHR Pharma
Yahoo/Benzinga
Wed, 12/14/16 - 09:17 am
Fovista
Ohr Pharmaceutical
Ophthotech
Regeneron
rinucumab
squalamine
wet age-related macular degeneration
Ophthotech Plunges on Eye Drug Study Failure
TheStreet.com
Mon, 12/12/16 - 09:17 am
Ophthotech
clinical trials
Fovista
Lucentis
wet age-related macular degeneration
The Street Is Getting The Ophthotech Story All Wrong
Yahoo/Benzinga
Sun, 10/30/16 - 11:18 am
Ophthotech
Fovista
Hard To See If Regeneron's Eylea Combo Study Failure Reads Through To Ophthotech's Fovista
Yahoo/Benzinga
Tue, 10/4/16 - 10:17 am
Regeneron
Eylea
clinical trials
Ophthotech
Fovista
10 Must-Know Biotech Stock Events to Close Out 2016
TheStreet.com
Fri, 09/9/16 - 09:04 pm
biotech
Eli Lilly
solanezumab
Biogen
aducanumab
Kite Pharma
KTE-C19
Bluebird Bio
LentiGlobin
Sarepta Therapeutics
eteplirsen
Ophthotech
Fovista
Bristol-Myers Squibb
Opdvio
Acadia
Nuplazid
Celgene
GED-301
Gilead Sciences
M&A
3 Biotechs Expecting Market-Moving Trial Results Soon
Motley Fool
Mon, 06/6/16 - 11:07 am
biotech
Ophthotech
Achillion
Kite Pharma
odalasvir
JNJ
Fovista
KTE-C19
3 Small-Cap Biotech Stocks With Big News Coming in 2016
Motley Fool
Sat, 12/12/15 - 02:05 pm
biotech
Ophthotech
Fovista
andexanet alfa
Portola Pharmaceuticals
ACH-3102
Achillion
5 Drugs That Investors May Be Undervaluing
Motley Fool
Mon, 07/13/15 - 11:04 am
Amicus Therapeutics
Galafold
Receptos
ozanimod
GS-5816
Gilead Sciences
ACH-3102
Achillion
Ophthotech
Fovista
3 Little-Known Biotechs Working On Potential Blockbusters
Motley Fool
Sun, 03/29/15 - 11:42 am
Ophthotech
Fovista
Esperion Therapeutics. ETC-1002
Prothena
PRX-002
2 Tiny Biotechs That Could Have Blockbuster Opportunity
Motley Fool
Sat, 03/7/15 - 11:23 am
Ophthotech
Fovista
Portola Pharmaceuticals
This Tiny Biotech Hopes to Capture a Share of This $6 Billion Market
Motley Fool
Mon, 02/2/15 - 10:08 am
Ophthotech
Novartis
Regeneron
Fovista
Roche
Avastin
Eylea
Lucentis
wet age-related macular degeneration
Ophthotech deal with Novartis leaves Fovista well-positioned, says Stifel
The Fly on the Wall
Tue, 05/20/14 - 11:24 am
Ophthotech
Fovista
Novartis
wet age-related macular degeneration
wet-AMD
Regeneron drops 6% after Ophthotech reports positive data
The Fly on the Wall
Wed, 06/13/12 - 12:01 pm
Ophthotech
Regeneron
Roche
Lucentis
Fovista
Eylea
wet-AMD